# C_2010219EN.01001701.xml

| 13.8.2010 | EN | Official Journal of the European Union | C 219/17 |
| --- | --- | --- | --- |

13.8.2010

EN

Official Journal of the European Union

C 219/17

---

Prior notification of a concentration

(Case COMP/M.5957 — CD&R Fund VIII/Goldman Sachs/HGI)

Candidate case for simplified procedure

(Text with EEA relevance)

2010/C 219/06

| 1. | On 6 August 2010 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Clayton, Dubilier & Rice Fund VIII, L.P. (‘CD&R Fund VIII’, Cayman Islands) and The Goldman Sachs Group, Inc. (‘Goldman Sachs’, United States of America) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Harrington Group, Inc. (‘HGI’, United States of America) by way of purchase of shares. |
| --- | --- |

1.

On 6 August 2010 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Clayton, Dubilier & Rice Fund VIII, L.P. (‘CD&R Fund VIII’, Cayman Islands) and The Goldman Sachs Group, Inc. (‘Goldman Sachs’, United States of America) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Harrington Group, Inc. (‘HGI’, United States of America) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for CD&R Fund VIII: private equity fund, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for CD&R Fund VIII: private equity fund,

| — | for Goldman Sachs: bank holding company and global investment banking, securities and investment management firm, |
| --- | --- |

—

for Goldman Sachs: bank holding company and global investment banking, securities and investment management firm,

| — | for HGI: mail-order, home-site provider of specialty medical products serving chronic disease patients. HGI is mostly active in the United States of America. |
| --- | --- |

—

for HGI: mail-order, home-site provider of specialty medical products serving chronic disease patients. HGI is mostly active in the United States of America.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.5957 — CD&R Fund VIII/Goldman Sachs/HGI, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.5957 — CD&R Fund VIII/Goldman Sachs/HGI, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

1

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

2

---